SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-22-000089
Filing Date
2022-07-18
Accepted
2022-07-18 07:30:26
Documents
16
Period of Report
2022-07-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20220718.htm   iXBRL 8-K 44473
2 EX-99.1 ex991_vicineumprogramupd.htm EX-99.1 11907
6 ex991_vicineumprogramupd001.jpg GRAPHIC 257594
7 ex991_vicineumprogramupd002.jpg GRAPHIC 281100
8 ex991_vicineumprogramupd003.jpg GRAPHIC 280187
  Complete submission text file 0001485003-22-000089.txt   1331952

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20220718.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20220718_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20220718_pre.xml EX-101.PRE 13046
10 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20220718_htm.xml XML 11810
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 221088142
SIC: 2834 Pharmaceutical Preparations